{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:16:31Z","timestamp":1768806991869,"version":"3.49.0"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamaophthalmol.2020.5329","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T19:14:33Z","timestamp":1607022873000},"page":"143","source":"Crossref","is-referenced-by-count":8,"title":["Risk Factors and Disease Course for Blood-Brain Barrier Disruption\u2013Associated Maculopathy"],"prefix":"10.1001","volume":"139","author":[{"given":"Joseph M.","family":"Simonett","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison H.","family":"Skalet","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon J.","family":"Lujan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Neuwelt","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oregon Health & Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Ambady","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oregon Health & Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoebe","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"eoi200096r1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1227\/00006123-198007000-00007","article-title":"Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.","volume":"7","author":"Neuwelt","year":"1980","journal-title":"Neurosurgery"},{"issue":"4 pt 1","key":"eoi200096r2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7326\/0003-4819-94-4-449","article-title":"Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.","volume":"94","author":"Neuwelt","year":"1981","journal-title":"Ann Intern Med"},{"issue":"5","key":"eoi200096r3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/0002-9394(86)90536-2","article-title":"Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier.","volume":"102","author":"Millay","year":"1986","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"eoi200096r4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ajo.2007.03.057","article-title":"Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.","volume":"144","author":"Galor","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi200096r5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/bjo.2007.130062","article-title":"Maculopathy in patients with primary CNS lymphoma treated with chemotherapy in conjunction with blood-brain barrier disruption.","volume":"92","author":"Vicuna-Kojchen","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi200096r6","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3928\/23258160-20200108-01","article-title":"Maculopathy associated with osmotic blood- brain barrier disruption and chemotherapy in patients with primary CNS lymphoma.","volume":"51","author":"Simonett","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"21","key":"eoi200096r7","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2008.19.3789","article-title":"Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.","volume":"27","author":"Angelov","year":"2009","journal-title":"J Clin Oncol"},{"issue":"50","key":"eoi200096r8","doi-asserted-by":"publisher","first-page":"E11827","DOI":"10.1073\/pnas.1813217115","article-title":"Interplay of the Norrin and Wnt7a\/Wnt7b signaling systems in blood-brain barrier and blood-retina barrier development and maintenance.","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"eoi200096r9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12987-018-0109-2","article-title":"The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.","volume":"15","author":"Bosma","year":"2018","journal-title":"Fluids Barriers CNS"},{"issue":"9","key":"eoi200096r10","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1172\/JCI76431","article-title":"Canonical WNT signaling components in vascular development and barrier formation.","volume":"124","author":"Zhou","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"eoi200096r11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/ICB.0000000000000535","article-title":"Multimodal imaging during the evolution of blood-brain barrier disruption maculopathy.","volume":"13","author":"Pal","year":"2019","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"eoi200096r12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/OPX.0000000000001031","article-title":"SD-OCT and adaptive optics imaging of outer retinal tubulation.","volume":"94","author":"King","year":"2017","journal-title":"Optom Vis Sci"},{"issue":"12","key":"eoi200096r13","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16.","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi200096r14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0161-6420(89)32924-1","article-title":"Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation.","volume":"96","author":"Morgan","year":"1989","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi200096r15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ophtha.2013.10.014","article-title":"En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.","volume":"121","author":"Ferrara","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi200096r16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/neurosurgery\/46.1.51","article-title":"Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.","volume":"46","author":"McAllister","year":"2000","journal-title":"Neurosurgery"},{"issue":"20","key":"eoi200096r17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2773505\/jamaophthalmology_simonett_2020_oi_200096_1613153453.8765.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T19:03:01Z","timestamp":1613588581000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2773505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.5329","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}